feed,title,long_url,short_url
SeekingAlpha,Johnson & Johnson presents trial data for BALVERSA plus cetrelimab in bladder cancer,https://seekingalpha.com/news/3740774,
SeekingAlpha,Turning Point Brands falls 5% as FDA denies marketing order to premarket tobacco product application,https://seekingalpha.com/news/3740768,
SeekingAlpha,COTA exercises options for 18 additional buses from NFIâ€™s New Flyer,https://seekingalpha.com/news/3740773,
SeekingAlpha,Lagardere jumps after Vivendi agrees to raise stake,https://seekingalpha.com/news/3740772,
SeekingAlpha,The State Of REITs: September 2021 Edition,https://seekingalpha.com/article/4455771,
